GKOSGlaukos Corporation
GKOS
Glaukos Corporation909
Mkt Cap
$6.55BVolume
846,016.0052W High
$130.2352W Low
$73.16PE Ratio
-35.67GKOS Fundamentals
Price
$116.69Prev Close
$112.77Open
$112.2650D MA
$111.93Beta
1.26Avg. Volume
722,460.75EPS (Annual)
-$3.28P/B
10.23Rev/Employee
$463,840.95$6,285.11
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases...
Business Wire·18h ago
Capricorn Fund Managers Ltd Invests $6.78 Million in Glaukos Corporation $GKOS
Capricorn Fund Managers Ltd bought a new stake in shares of Glaukos Corporation (NYSE:GKOS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·21h ago
Glaukos Corporation $GKOS Shares Acquired by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC lifted its position in shares of Glaukos Corporation (NYSE:GKOS - Free Report) by 32.8% during the 4th quarter, according to its most recent filing with the...
MarketBeat·4d ago
SG Americas Securities LLC Purchases 49,492 Shares of Glaukos Corporation $GKOS
SG Americas Securities LLC boosted its position in shares of Glaukos Corporation (NYSE:GKOS - Free Report) by 460.8% during the 4th quarter, according to its most recent 13F filing with the...
MarketBeat·6d ago
Glaukos (NYSE:GKOS) CFO Sells $267,321.06 in Stock
Glaukos Corporation (NYSE:GKOS - Get Free Report) CFO Alex Thurman sold 2,511 shares of the business's stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of...
MarketBeat·10d ago
Riverbridge Partners LLC Sells 34,475 Shares of Glaukos Corporation $GKOS
Riverbridge Partners LLC reduced its stake in Glaukos Corporation (NYSE:GKOS - Free Report) by 6.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 535,169 shares of the medical instruments...
MarketBeat·11d ago
Assenagon Asset Management S.A. Has $20.59 Million Stock Position in Glaukos Corporation $GKOS
Assenagon Asset Management S.A. increased its stake in Glaukos Corporation (NYSE:GKOS - Free Report) by 15.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,393 shares of the medical instruments s...
MarketBeat·11d ago
Glaukos (NYSE:GKOS) CFO Sells $160,070.04 in Stock
Glaukos Corporation (NYSE:GKOS - Get Free Report) CFO Alex Thurman sold 1,521 shares of Glaukos stock in a transaction dated Tuesday, March 24th. The shares were sold at an average price of $105.24, for a total transaction of $160,070.04. Following the sale, the chief financial officer directly...
MarketBeat·12d ago
Insider Selling: Glaukos (NYSE:GKOS) CFO Sells 1,521 Shares of Stock
Glaukos Corporation (NYSE:GKOS - Get Free Report) CFO Alex Thurman sold 1,521 shares of the stock in a transaction that occurred on Tuesday, March 24th. The shares were sold at an average price of $105.24, for a total transaction of $160,070.04. Following the completion of the sale, the chief...
MarketBeat·12d ago
JPMorgan Chase & Co. Has $54.65 Million Stock Position in Glaukos Corporation $GKOS
JPMorgan Chase & Co. increased its holdings in Glaukos Corporation (NYSE:GKOS - Free Report) by 4.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 670,083 shares of the medical instruments su...
MarketBeat·17d ago
<
1
2
...
>